An implant is meant to live inside the body for years or decades. When it ruptures, erodes, or corrodes before it should, the explant itself usually holds the record of why.
Start a conversation with our AI Research Concierge, already scoped to implant failure. Pick a starting point, or describe your situation directly.
Implants fail differently than almost anything else this department investigates, because the evidence sits inside a biological environment that is actively working on the device from the moment it is placed. A silicone shell fatigues under decades of physiologic motion; a surgical mesh can erode through the tissue it was meant to reinforce; a cardiac lead's insulation abrades at the point where it flexes against a rib or clavicle; a modular metal junction corrodes in the crevice where two components meet, releasing ions the body reacts to. None of this happens in isolation from the patient's biology, which is why implant investigations lean as heavily on retrieval protocol and histopathology correlation as they do on materials science.
Soft-tissue and general implantable failures cluster around a handful of mechanisms, each with a distinct signature at explant.
A foreign-body and, in some cases, biofilm-mediated response producing a tightening fibrous capsule around a breast implant or other soft-tissue device.
Fatigue cracking of a silicone shell, valve failure, or slow diffusion of gel through an intact shell over years of physiologic loading.
Surgical mesh eroding into adjacent bowel, bladder, or vaginal tissue, or migrating from its original placement site with associated adhesion formation.
Cardiac or neurostimulator lead insulation abrasion and conductor fracture at flexion points, typically where the lead crosses a bony structure.
Crevice and fretting corrosion where two dissimilar-metal or micromotion-prone components meet, releasing metal ions and generating debris.
Bacterial biofilm colonizing the implant surface, compromising structural integrity and driving a chronic inflammatory response that mimics mechanical failure.
Implant retrieval analysis depends on preserving the explant exactly as it came out — surface condition and orientation are the evidence.
An implant failure finding tends to reach well beyond the individual patient:
Rinsing, fixing in the wrong medium, or discarding the explanted device destroys the surface evidence — corrosion products, wear debris, and biofilm — that identifies the mechanism. Coordinate retrieval with the lab before surgery where possible.
Some degree of fibrous encapsulation and tissue response is expected around any implant — the question is whether the response is proportionate, and whether it was driven by a device defect such as a rough surface finish, contamination, or a material outside specification. That determination compares the explant's surface condition and material properties against the design specification, alongside the histopathology, rather than the clinical outcome alone.
Often yes, though it usually requires both the explant and the operative record. Erosion driven by a material or design issue tends to show consistent, product-specific degradation patterns across multiple patients with the same device; erosion tied to technique tends to correlate with placement location, tension, or fixation method documented in the operative note. Comparing the case against the manufacturer's adverse-event history for the same mesh product is often informative.
By the fracture and edge characteristics. A rupture that occurred in vivo shows fatigue striations, gradual thinning, or chemical degradation consistent with years of physiologic loading; a surgical or handling artifact shows a sharp, fresh cut edge with none of that history. SEM examination of the fracture surface is usually decisive, which is why preserving the explant without additional cutting matters.
Biofilm can both cause and be mistaken for mechanical failure. A biofilm-colonized implant can trigger a chronic inflammatory response that looks like a device malfunction, and biofilm-associated corrosion can accelerate material degradation that would otherwise progress far more slowly. Identifying biofilm requires specific staining and imaging protocols coordinated with the pathology lab, since it is not reliably visible on gross examination.
The lead is imaged first — fluoroscopy or CT localizes the fracture site, which is frequently at a point of chronic mechanical flexion such as the clavicle-first rib interval. The explanted lead is then examined under SEM for fatigue striations in the conductor and abrasion patterns in the insulation, and the fracture location is checked against the implant technique and lead routing documented at the original procedure.
Technical briefings from our work in this area.
A modular junction is a crevice with micromotion in it. Reading the degradation means examining the surfaces before cleaning, verifying the alloy, and addressing assembly and patient factors explicitly.
readMost of what an explanted implant could prove is decided in theatre, not in the laboratory. Cleaning, fixation and sterilisation remove the surface record before anyone identifies it as evidence.
readA worn implant surface and the tissue around it answer different questions. Reading the wear mode, characterising the debris, and establishing the host reaction are separate acts of evidence.
readTell us what happened. We will triage it and connect you with the right expert — usually within one business day.